These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10806816)

  • 1. Hormone secretion by cell culture of human GH-PRL secreting pituitary adenomas: effects of bromocriptine.
    Lei T; Bai X; Liu K; Hu W; Xue D; Jiang X
    J Tongji Med Univ; 1998; 18(3):161-3. PubMed ID: 10806816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.
    Hofland LJ; de Herder WW; Waaijers M; Zuijderwijk J; Uitterlinden P; van Koetsveld PM; Lamberts SW
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3336-43. PubMed ID: 10487708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein hormone alpha-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release.
    Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW
    Clin Endocrinol (Oxf); 1989 Jun; 30(6):601-11. PubMed ID: 2512040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytocidal effects of bromocriptine, somatostatin analog, and heat on growth hormone-secreting pituitary adenoma in vitro.
    Kawamoto K; Uozumi T; Sakoda K; Mukada K; Kurisu K; Yano T
    Cancer; 1992 Jun; 69(11):2688-96. PubMed ID: 1571899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells.
    Johansen PW; Haug E; Gautvik KM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):200-6. PubMed ID: 4060970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inversely related evolution of growth hormone and prolactin secretions in long-term tissue cultures of human pituitary adenomas from acromegalic patients.
    Loras B; Trouillas J; Li Y; Durand A; Girod C; Bertrand J
    In Vitro Cell Dev Biol; 1988 Nov; 24(11):1064-70. PubMed ID: 3192504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of insulin-like growth factor-I on growth hormone and prolactin secretion and cell proliferation of human somatotrophinomas and prolactinomas in vitro.
    Atkin SL; Landolt AM; Foy P; Jeffreys RV; Hipkin L; White MC
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):503-9. PubMed ID: 7525124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
    Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatomammotrophic cells in GH-secreting and PRL-secreting human pituitary adenomas.
    Bassetti M; Brina M; Spada A; Giannattasio G
    J Endocrinol Invest; 1989 Nov; 12(10):705-12. PubMed ID: 2614009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monolayer and suspension culture of human prolactin-secreting pituitary adenoma.
    Kletzky OA; Marrs RP; Rundall TT; Weiss MH; Beierle JW
    Am J Obstet Gynecol; 1980 Nov; 138(6):660-4. PubMed ID: 7435530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of somatotrophs, mammosomatotrophs, and mammotrophs by sandwich cell immunoblot assay in GH-secreting adenomas and prolactinomas: correlations between the proportions of hormone secreting cells and tumor size.
    Kojima Y; Suzuki S; Yamamura K; Kawasaki T; Yamamoto I
    Endocr J; 2000 Apr; 47(2):143-55. PubMed ID: 10943738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
    Lloyd HM; Jacobi JM; Willgoss DA
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and morphological findings in two cases of bromocriptine-treated prolactinomas.
    Anniko M; Wersäll J
    Acta Pathol Microbiol Scand A; 1981 Jan; 89(1):41-7. PubMed ID: 7223426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
    Chen Y; Gao H; Xie W; Guo J; Fang Q; Zhao P; Liu C; Zhu H; Wang Z; Wang J; Gui S; Zhang Y; Li C
    Aging (Albany NY); 2020 Dec; 13(1):1276-1293. PubMed ID: 33472173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH.
    Bevan JS; Burke CW
    Clin Endocrinol (Oxf); 1989 Jun; 30(6):667-80. PubMed ID: 2512041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.